What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
Vincent Cottin mainly investigates Internal medicine, Idiopathic pulmonary fibrosis, Surgery, Pathology and Interstitial lung disease.
Internal medicine and Gastroenterology are frequently intertwined in his study.
His Idiopathic pulmonary fibrosis research is multidisciplinary, incorporating perspectives in Exacerbation, Adverse effect, Etiology and Intensive care medicine.
His biological study spans a wide range of topics, including Clinical trial, Bosentan, Sildenafil, Pharmacotherapy and Radiology.
He works mostly in the field of Pathology, limiting it down to concerns involving Lung and, occasionally, Retrospective cohort study.
His Interstitial lung disease study combines topics in areas such as Autoantibody, Guideline, Connective tissue disease and Rheumatoid arthritis.
His most cited work include:
- Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis (2009 citations)
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era (1075 citations)
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. (910 citations)
What are the main themes of his work throughout his whole career to date?
Vincent Cottin mainly focuses on Internal medicine, Idiopathic pulmonary fibrosis, Pathology, Interstitial lung disease and Gastroenterology.
His work in the fields of FEV1/FVC ratio, Nintedanib and Pulmonary hypertension overlaps with other areas such as In patient.
He studied FEV1/FVC ratio and Placebo that intersect with Clinical endpoint and Adverse effect.
His work deals with themes such as Vascular resistance, Pulmonary function testing and Combined pulmonary fibrosis and emphysema, which intersect with Pulmonary hypertension.
The Idiopathic pulmonary fibrosis study combines topics in areas such as Pulmonary fibrosis, Clinical trial, Surgery and Intensive care medicine.
He combines subjects such as Idiopathic interstitial pneumonia and Lung with his study of Pathology.
He most often published in these fields:
- Internal medicine (50.45%)
- Idiopathic pulmonary fibrosis (29.94%)
- Pathology (19.91%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (50.45%)
- Idiopathic pulmonary fibrosis (29.94%)
- FEV1/FVC ratio (14.82%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Idiopathic pulmonary fibrosis, FEV1/FVC ratio, In patient and Interstitial lung disease.
Vincent Cottin has included themes like Gastroenterology and Cardiology in his Internal medicine study.
He interconnects Diffusing capacity and Combined pulmonary fibrosis and emphysema in the investigation of issues within Cardiology.
His research in Idiopathic pulmonary fibrosis intersects with topics in Pulmonologists, Intensive care medicine and Pulmonary fibrosis.
The various areas that he examines in his FEV1/FVC ratio study include Respiratory function and Placebo.
His Interstitial lung disease research is multidisciplinary, relying on both Fibrosis, Epidemiology, Pathology and Cause of death.
Between 2019 and 2021, his most popular works were:
- Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. (91 citations)
- Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial (55 citations)
- Predictors of progression in systemic sclerosis patients with interstitial lung disease (22 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
The scientist’s investigation covers issues in Internal medicine, FEV1/FVC ratio, Interstitial lung disease, Idiopathic pulmonary fibrosis and Vital capacity.
His Internal medicine study frequently links to other fields, such as Gastroenterology.
His work carried out in the field of FEV1/FVC ratio brings together such families of science as Spirometry, Placebo, Nintedanib and Pirfenidone.
The study incorporates disciplines such as Fibrosis, Diffusing capacity, Disease and Hemodynamics in addition to Interstitial lung disease.
His Idiopathic pulmonary fibrosis research is within the category of Lung.
His Vital capacity research focuses on DLCO and how it relates to Lung volumes, Birt–Hogg–Dubé syndrome, Folliculin, Pneumothorax and Respiratory function.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
